Menopause: A Sudden Physiological Shift, Not a Gradual Fade

5:05 PM | dr Oz
TABLE OF CONTENTS
    Population-scale reconstruction of menopause dynamics reveals a physiological cliff at the final menstrual period | Nature Medicine
    Menopause: A Sudden Physiological Shift, Not a Gradual Fade

    OZ.VGI.CO.ID - For decades, menopause has been broadly understood as a slow, winding down of a woman's reproductive capacity. However, new research utilizing massive datasets and a novel computational approach suggests this transition may be more abrupt, akin to a "physiological cliff," fundamentally reshaping female bodily functions at the time of the final menstrual period (FMP). This paradigm shift challenges existing models and offers a more precise understanding of how hormonal changes impact numerous bodily systems.

    The Limitations of Past Research

    Previous studies, such as the well-regarded Study of Women’s Health Across the Nation (SWAN), have provided invaluable insights into the menopause transition.

    These longitudinal studies, which follow participants over time, have indicated that hormonal shifts can begin as early as seven years before menopause and that bone loss accelerates around this period.

    Despite their importance, such studies are inherently limited by their relatively small participant numbers and the constrained scope of laboratory tests conducted.

    Furthermore, the exact timing of the final menstrual period (FMP) is often not meticulously recorded in large-scale biomedical datasets, making it difficult to pinpoint physiological changes relative to this crucial biological event.

    This lack of precise temporal anchoring has meant that vast repositories of health data, containing millions of laboratory tests, have remained largely underutilized for studying menopause dynamics.

    Researchers typically rely on chronological age, which acts as a blurring factor.

    Imagine trying to understand the timeline of a concert by only knowing the ages of people in the audience, rather than when each song was played.

    This is the challenge faced when studying menopause without precise FMP data.

    A New Computational Framework for Unveiling Menopause Dynamics

    To overcome these limitations, a team of researchers developed an innovative computational framework inspired by techniques used in astronomy to sharpen blurry images.

    This method, dubbed the "YoGlen" algorithm, effectively "deblurs" physiological trajectories by statistically accounting for the variation in FMP timing across individuals.

    By analyzing cross-sectional data – snapshots of health information taken at a single point in time from many individuals – and deconvoluting the known distribution of FMP ages, scientists can reconstruct a more accurate timeline of physiological changes anchored to the FMP.

    This sophisticated approach was applied to two independent, large-scale datasets: the National Health and Nutrition Examination Survey (NHANES), a US-based health and aging study spanning from 1999 to 2022, and a dataset from the Israeli health insurer Clalit, encompassing approximately half the Israeli population from 2004 to 2024.

    Combined, these analyses examined over 300 million laboratory tests from more than 1 million female individuals aged 30-70 years.

    Exclusions were made for individuals taking specific medications or with diagnosed conditions known to affect the tests in question, ensuring the data reflected natural physiological changes in non-pregnant individuals.

    The 'Physiological Cliff' at Menopause

    The findings revealed a striking pattern: instead of a gradual decline, numerous physiological systems exhibit a distinct, step-like change – a "cliff" – precisely at the FMP.

    This abrupt shift was observed across endocrine, skeletal, hepatic (liver), renal (kidney), and lipid systems.

    For instance, in the NHANES dataset, the iron-related test, ferritin, showed a significant jump of 0.6 standard deviations (s.d.) when adjusted for time to menopause.

    Across the analysis of 90 different laboratory tests, 52 showed a significant jump in women, a phenomenon not observed in men when the same analytical approach was applied (interpreting age 50 as a reference point for men).

    The magnitude of these jumps varied, ranging from 0.1 to 1.4 s.d.

    Large jumps, exceeding 0.5 s.d., were particularly evident in sex hormones such as estradiol (E2), anti-Müllerian hormone (AMH), and follicle-stimulating hormone (FSH), aligning with expectations and previous longitudinal data.

    However, the extent of these abrupt changes in numerous other systems was a significant finding, indicating a widespread physiological response to the cessation of menstruation.

    Absence in Males and Concordance Across Populations

    Crucially, these physiological discontinuities were not observed in the analysis of male individuals, highlighting the sex-specific nature of this transition.

    Furthermore, the observed jump sizes in laboratory tests were highly concordant between the US (NHANES) and Israeli (Clalit) cohorts, with a correlation coefficient (r) of 0.89.

    This strong agreement, even across different populations and study designs, suggests that the physiological cliff at menopause is a robust and generalizable phenomenon.

    Early Dysregulation and the Role of Hormone Therapy

    Perhaps one of the most compelling discoveries is that the physiological dysregulation leading to these changes appears to begin more than a decade before the FMP.

    This suggests a prolonged pre-menopausal period where underlying physiological shifts are already underway, culminating in the abrupt changes observed at menopause.

    The study also investigated the impact of menopausal hormone therapy (MHT), previously known as hormone replacement therapy (HRT).

    Analysis of NHANES participants using MHT indicated that these therapies can significantly attenuate the observed jumps at menopause.

    The larger the jump in a particular test, the greater the observed correction with MHT, with a strong correlation (r=0.76) between jump size and MHT's mitigating effect.

    This attenuation was particularly noticeable in systems like bone, liver, and kidney/osmolality.

    While MHT did not normalize all changes, its impact on mitigating the sharp declines in various physiological markers is a significant finding.

    Notably, tests related to iron, hemoglobin, and red blood cells showed improvement post-menopause, likely due to the cessation of menstrual bleeding, an exception to the general trend of deterioration.

    Implications for Future Research and Healthcare

    This research offers a powerful new framework for understanding not only menopause but also other critical life transitions such as puberty or the progression of chronic diseases.

    By enabling the reconstruction of hidden biological trajectories from large, cross-sectional datasets, the "deblurring" technique allows for a more granular and accurate temporal analysis.

    This systemic and quantifiable view of menopause could revolutionize how we approach women's health, paving the way for earlier identification of risks and more targeted interventions.

    It is important to note that while this study reveals significant physiological shifts and the potential benefits of MHT, individual experiences can vary widely.

    Decisions regarding menopausal health and hormone therapy should always be made in consultation with a qualified healthcare professional who can assess individual medical history, risk factors, and specific needs.

    Comments